September/Octobert 2000

Vol 7, No 5 CME Pretest

This Journal provides 4 hours of Category 1 Continuing Medical Education

Complimentary CME Credits

Physicians can earn 4 credit hours of Category 1 for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions in the posttest at the end of this issue. Complete instructions are given on the posttest pages. Successfully answering 30 or more questions will earn 4 credit hours. CME is presented by an unrestricted educational grant from Bristol-Myers Squibb Oncology Division.

Educational Objectives

After reading this issue of Cancer Control, clinicians will be expected to:

• improve the accuracy of diagnosis and staging of patients with pancreatic cancer,
• discuss the salient aspects of molecular events in pancreatic cancer,
• implement potentially curable and palliative measures, and
• better utilize evidence-based management.

This program was planned in accordance with ACCME Essentials.

Release Date: September 1, 2000
Expiration Date: September 1, 2001

1. The detection rate for standard CT imaging for a pancreatic neoplasm that is less than 2 cm in diameter is:

a. 16%
b. 29%
c. 57%
d. 84%

2. Which is the usual first site of metastasis in patients with pancreatic cancer treated by pancreatectomy?

a. peritoneum
b. lung
c. nodal basin
d. liver

3. What is the most appropriate use of evidence-based medicine for managed care organizations?

a. develop guidelines
b. monitor care
c. standardize management
d. reduce costs